Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SQ-31765 is a blocker of benzazepine calcium channel.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,670.00 | |
50 mg | 6-8 weeks | $ 2,180.00 | |
100 mg | 6-8 weeks | $ 2,800.00 |
Description | SQ-31765 is a blocker of benzazepine calcium channel. |
In vivo | SQ-31765 (SQ 31,765) effectively mitigates the severity of ischemia independent of myocardial blood flow or hemodynamic changes. In a study, anesthetized dogs were administered either saline (n=6), SQ-31765 (n=6; 0.2 mg/kg), or SQ 32,189 (n=6; 0.2 mg/kg) intravenously 10 minutes prior to inducing ischemia. The research focused on the compound's impact on pacing-induced ST-segment elevation and myocardial blood flow during left anterior descending coronary artery stenosis. SQ-31765 significantly lowered ST-segment elevation (P<0.05) at 10, 40, and 70 minutes post-infusion, showcasing a notable reduction (5.9±1.4 mV at 70 minutes) compared to the saline group (12.0±1.4 mV at 70 minutes). All test groups exhibited a marked decrease in subendocardial flow due to left anterior descending coronary artery stenosis during atrial pacing prior to drug administration, underscoring SQ-31765's protective effects against pacing-induced myocardial injury. |
Molecular Weight | 464.48 |
Formula | C24H27F3N2O4 |
CAS No. | 138383-07-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SQ-31765 138383-07-0 Membrane transporter/Ion channel Metabolism Calcium Channel SQ31765 SQ 31765 inhibitor inhibit